Roger C. Inhorn

机构：Pen Bay Medical Center

发表论文 14 篇 · 总被引 883 次 · h-index 10

代表论文

• Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial (2017 · The Lancet Oncology · 被引 595)
• JAK2 Associates with the β c Chain of the Receptor for Granulocyte-Macrophage Colony-Stimulating Factor, and Its Activation Requires the Membrane-Proximal Region (1994 · Molecular and Cellular Biology · 被引 88)
• The Murine DUB-1 Gene Is Specifically Induced by the βc Subunit of the Interleukin-3 Receptor (1996 · Molecular and Cellular Biology · 被引 55)
• A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer (2010 · Breast Cancer Research and Treatment · 被引 28)
• TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer (2017 · Breast Cancer Research and Treatment · 被引 27)
• A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer (2010 · Clinical Breast Cancer · 被引 20)